243 related articles for article (PubMed ID: 29713652)
21. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.
Reeves RK; Gillis J; Wong FE; Yu Y; Connole M; Johnson RP
Blood; 2010 Jun; 115(22):4439-46. PubMed ID: 20339088
[TBL] [Abstract][Full Text] [Related]
22. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
Saito S; Morii T; Enomoto M; Sakakura S; Nishikawa K; Narita N; Ichijo M
Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983
[TBL] [Abstract][Full Text] [Related]
23. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.
Mirjačić Martinović K; Babović N; Džodić R; Jurišić V; Matković S; Konjević G
J Transl Med; 2015 Apr; 13():120. PubMed ID: 25889680
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.
Cifaldi L; Prencipe G; Caiello I; Bracaglia C; Locatelli F; De Benedetti F; Strippoli R
Arthritis Rheumatol; 2015 Nov; 67(11):3037-46. PubMed ID: 26251193
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 4 (IL-4) blocks the IL-2-induced increased in natural killer activity and DNA synthesis of decidual CD16-CD56bright NK cells by inhibiting expression of the IL-2 receptor alpha, beta, and gamma.
Saito S; Umekage H; Nishikawa K; Morii T; Narita N; Enomoto M; Sakakura S; Harada N; Ichijo M; Morikawa H
Cell Immunol; 1996 May; 170(1):71-7. PubMed ID: 8660801
[TBL] [Abstract][Full Text] [Related]
26. A large quantity of CD3-/CD19-/CD16- lymphocytes in malignant pleural effusion from a patient with recurrent cholangio cell carcinoma.
Onishi H; Morisaki T; Kuga H; Katano M; Doi F; Uchiyama A; Sugitani A; Wada J; Chijiiwa K; Tanaka M
Immunol Invest; 2002 May; 31(2):121-35. PubMed ID: 12148948
[TBL] [Abstract][Full Text] [Related]
27. Decidual cell regulation of natural killer cell-recruiting chemokines: implications for the pathogenesis and prediction of preeclampsia.
Lockwood CJ; Huang SJ; Chen CP; Huang Y; Xu J; Faramarzi S; Kayisli O; Kayisli U; Koopman L; Smedts D; Buchwalder LF; Schatz F
Am J Pathol; 2013 Sep; 183(3):841-56. PubMed ID: 23973270
[TBL] [Abstract][Full Text] [Related]
28. dNK cells facilitate the interaction between trophoblastic and endothelial cells via VEGF-C and HGF.
Ma L; Li G; Cao G; Zhu Y; Du MR; Zhao Y; Wang H; Liu Y; Yang Y; Li YX; Li DJ; Yang H; Wang YL
Immunol Cell Biol; 2017 Sep; 95(8):695-704. PubMed ID: 28653669
[TBL] [Abstract][Full Text] [Related]
29. Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors.
Cerdeira AS; Rajakumar A; Royle CM; Lo A; Husain Z; Thadhani RI; Sukhatme VP; Karumanchi SA; Kopcow HD
J Immunol; 2013 Apr; 190(8):3939-48. PubMed ID: 23487420
[TBL] [Abstract][Full Text] [Related]
30. Soluble HLA class I molecules in malignant pleural and peritoneal effusions and its possible role on NK and LAK cytotoxicity.
Amirghofran Z; Sheikhi AK; Kumar PV; Saberi Firouzi M
J Cancer Res Clin Oncol; 2002 Aug; 128(8):443-8. PubMed ID: 12200601
[TBL] [Abstract][Full Text] [Related]
31. Decidualization-derived cAMP promotes decidual NK cells to be angiogenic phenotype.
Jin X; Mao L; Zhao W; Liu L; Li Y; Li D; Zhang Y; Du M
Am J Reprod Immunol; 2022 Sep; 88(3):e13540. PubMed ID: 35348271
[TBL] [Abstract][Full Text] [Related]
32. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
33. Circulating NK cells and their subsets in Behçet's disease.
Hasan MS; Ryan PL; Bergmeier LA; Fortune F
Clin Exp Immunol; 2017 May; 188(2):311-322. PubMed ID: 28170096
[TBL] [Abstract][Full Text] [Related]
34. Decidual-Like NK Cell Polarization: From Cancer Killing to Cancer Nurturing.
Albini A; Noonan DM
Cancer Discov; 2021 Jan; 11(1):28-33. PubMed ID: 33277305
[TBL] [Abstract][Full Text] [Related]
35. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
36. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity.
Hazeldine J; Hampson P; Lord JM
Aging Cell; 2012 Oct; 11(5):751-9. PubMed ID: 22642232
[TBL] [Abstract][Full Text] [Related]
37. Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.
Stabile H; Nisti P; Morrone S; Pagliara D; Bertaina A; Locatelli F; Santoni A; Gismondi A
Haematologica; 2015 Apr; 100(4):489-98. PubMed ID: 25596273
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-8 production by CD16-CD56bright natural killer cells in the human early pregnancy decidua.
Saito S; Kasahara T; Sakakura S; Enomoto M; Umekage H; Harada N; Morii T; Nishikawa K; Narita N; Ichijo M
Biochem Biophys Res Commun; 1994 Apr; 200(1):378-83. PubMed ID: 7513162
[TBL] [Abstract][Full Text] [Related]
39. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.
Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C
Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474
[TBL] [Abstract][Full Text] [Related]
40. Unique Eomes(+) NK Cell Subsets Are Present in Uterus and Decidua During Early Pregnancy.
Montaldo E; Vacca P; Chiossone L; Croxatto D; Loiacono F; Martini S; Ferrero S; Walzer T; Moretta L; Mingari MC
Front Immunol; 2015; 6():646. PubMed ID: 27004067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
